Ashkenazi Jewish origin protects against formation of antibodies to infliximab and therapy failure.
Ungar B, Haj-Natour O, Kopylov U, Yavzori M, Fudim E, Picard O, Loebstein R, Lahat A, Maor Y, Avidan B, Lang A, Weiss B, Chowers Y, Eliakim R, Ben-Horin S.
Ungar B, et al. Among authors: maor y.
Medicine (Baltimore). 2015 May;94(18):e673. doi: 10.1097/MD.0000000000000673.
Medicine (Baltimore). 2015.
PMID: 25950682
Free PMC article.